Arrowhead Pharmaceuticals, Inc.

ARWR · Healthcare

$82.74

Capitalización: 11.69B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Arrowhead Pharmaceuticals, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Insider Monkey4 sept 2026, 16:15

Arrowhead (ARWR) Reported a 78% Lower Pancreatitis Event Rate With Plozasiran. Does the Absolute Benefit Support a Broader Label?

Barrons.com4 sept 2026, 16:13

This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.

Business Wire3 sept 2026, 11:30

Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences

Simply Wall St.1 sept 2026, 11:09

Is Arrowhead Pharmaceuticals (ARWR) Undervalued As SHASTA 3 And SHASTA 4 Data Impress?